...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
【24h】

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.

机译:基于18FDG-PET的有限疾病小细胞肺癌纵隔淋巴结放疗规划改变了放疗领域:一项规划研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: To investigate the influence of selective irradiation of 18FDG-PET positive mediastinal nodes on radiation fields and normal tissue exposure in limited disease small cell lung cancer (LD-SCLC). MATERIAL AND METHODS: Twenty-one patients with LD-SCLC, of whom both CT and PET images were available, were studied. For each patient, two three-dimensional conformal treatment plans were made with selective irradiation of involved lymph nodes, based on CT and on PET, respectively. Changes in treatment plans as well as dosimetric factors associated with lung and esophageal toxicity were analyzed and compared. RESULTS: FDG-PET information changed the treatment field in 5 patients (24%). In 3 patients, this was due to a decrease and in 2 patients to an increase in the number of involved nodal areas. However, there were no significant differences in gross tumor volume (GTV), lung, and esophageal parameters between CT- and PET-based plans. CONCLUSIONS: Incorporating FDG-PET information in radiotherapy planning for patients with LD-SCLC changed the treatment plan in 24% of patients compared to CT. Both increases and decreases of the GTV were observed, theoretically leading to the avoidance of geographical miss or a decrease of radiation exposure of normal tissues, respectively. Based on these findings, a phase II trial, evaluating PET-scan based selective nodal irradiation, is ongoing in our department.
机译:背景与目的:探讨选择性疾病小细胞肺癌(LD-SCLC)对18FDG-PET阳性纵隔淋巴结的选择性照射对辐射场和正常组织暴露的影响。材料与方法:研究了21例LD-SCLC患者,他们均具有CT和PET图像。针对每位患者,分别基于CT和PET制定了两个三维立体适形治疗计划,分别对受累的淋巴结进行了选择性照射。分析并比较了治疗方案的变化以及与肺部和食道毒性有关的剂量学因素。结果:FDG-PET信息改变了5例患者(24%)的治疗范围。在3例患者中,这是由于减少的,在2例患者中是由于累及的淋巴结区域的数量增加。但是,基于CT和PET的计划之间的总肿瘤体积(GTV),肺和食管参数没有显着差异。结论:与CT相比,将LDG-PET信息纳入LD-SCLC患者的放射治疗计划中改变了24%的患者的治疗计划。观察到GTV的增加和减少,从理论上分别避免地理缺失或减少正常组织的辐射暴露。基于这些发现,我们部门正在进行一项II期试验,评估基于PET扫描的选择性淋巴结照射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号